UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 1, 2022

Accession Number:	0001628280-22-003863
Submission Type:	POS AM
CIK: 0001808805 Company Name: Nautilus Biotechnology, Inc. File Number: 333-258100